Baidu
map

Sci Rep:mRNA剪接相关基因的变异与肺癌相关!

2017-03-19 MedSci MedSci原创

mRNA剪接是调节mRNA表达的重要机制。这个过程的异常调节可能导致肺癌的发生。近期,一项发表在杂志Sci Rep上的研究调查了206 mRNA剪接相关基因与肺癌风险关联的11,966个单核苷酸多态性(SNPs)。研究者们从六个已发表的肺癌(TRICL)跨学科全基因组关联研究(GWASs)(12,160例病例和16,838例对照),另外两个哈佛大学的肺癌GWAS(984例病例和970例对照)以及d

mRNA剪接是调节mRNA表达的重要机制。这个过程的异常调节可能导致肺癌的发生。


近期,一项发表在杂志Sci Rep上的研究调查了206 mRNA剪接相关基因与肺癌风险关联的11,966个单核苷酸多态性(SNPs)。

研究者们从六个已发表的肺癌(TRICL)跨学科全基因组关联研究(GWASs)(12,160例病例和16,838例对照),另外两个哈佛大学的肺癌GWAS(984例病例和970例对照)以及deCODE(1,319例病例和26,380例对照)中使用摘要数据。

研究者们发现总共有12个显着SNPs与假发现率(FDR)≤0.05映射到一个新基因PRPF6和两个以前报告的基因(DHX16和LSM2)。

PRPF6中的六个新型SNP处于高连锁不平衡中,并与来自373位欧洲人在1000基因组计划中的淋巴母细胞中的PRPF6 mRNA表达相关。

此项研究揭示了mRNA剪接基因在肺癌发展中的作用。

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2029292, encodeId=a88e202929292, content=<a href='/topic/show?id=9c52e253016' target=_blank style='color:#2F92EE;'>#相关基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72530, encryptionId=9c52e253016, topicName=相关基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Tue May 23 03:01:00 CST 2017, time=2017-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642594, encodeId=4dee1642594df, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Aug 10 15:01:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183609, encodeId=6bac18360942, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Wed Mar 29 23:39:56 CST 2017, time=2017-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342377, encodeId=d42613423e7ea, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Mar 21 03:01:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181134, encodeId=09d118113438, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Mar 19 12:51:54 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181127, encodeId=be8618112e05, content=涨知识了,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 19 12:45:28 CST 2017, time=2017-03-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2029292, encodeId=a88e202929292, content=<a href='/topic/show?id=9c52e253016' target=_blank style='color:#2F92EE;'>#相关基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72530, encryptionId=9c52e253016, topicName=相关基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Tue May 23 03:01:00 CST 2017, time=2017-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642594, encodeId=4dee1642594df, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Aug 10 15:01:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183609, encodeId=6bac18360942, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Wed Mar 29 23:39:56 CST 2017, time=2017-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342377, encodeId=d42613423e7ea, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Mar 21 03:01:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181134, encodeId=09d118113438, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Mar 19 12:51:54 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181127, encodeId=be8618112e05, content=涨知识了,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 19 12:45:28 CST 2017, time=2017-03-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2029292, encodeId=a88e202929292, content=<a href='/topic/show?id=9c52e253016' target=_blank style='color:#2F92EE;'>#相关基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72530, encryptionId=9c52e253016, topicName=相关基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Tue May 23 03:01:00 CST 2017, time=2017-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642594, encodeId=4dee1642594df, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Aug 10 15:01:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183609, encodeId=6bac18360942, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Wed Mar 29 23:39:56 CST 2017, time=2017-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342377, encodeId=d42613423e7ea, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Mar 21 03:01:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181134, encodeId=09d118113438, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Mar 19 12:51:54 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181127, encodeId=be8618112e05, content=涨知识了,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 19 12:45:28 CST 2017, time=2017-03-19, status=1, ipAttribution=)]
    2017-03-29 laymankey

    感谢分享一下!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2029292, encodeId=a88e202929292, content=<a href='/topic/show?id=9c52e253016' target=_blank style='color:#2F92EE;'>#相关基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72530, encryptionId=9c52e253016, topicName=相关基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Tue May 23 03:01:00 CST 2017, time=2017-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642594, encodeId=4dee1642594df, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Aug 10 15:01:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183609, encodeId=6bac18360942, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Wed Mar 29 23:39:56 CST 2017, time=2017-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342377, encodeId=d42613423e7ea, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Mar 21 03:01:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181134, encodeId=09d118113438, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Mar 19 12:51:54 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181127, encodeId=be8618112e05, content=涨知识了,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 19 12:45:28 CST 2017, time=2017-03-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2029292, encodeId=a88e202929292, content=<a href='/topic/show?id=9c52e253016' target=_blank style='color:#2F92EE;'>#相关基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72530, encryptionId=9c52e253016, topicName=相关基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Tue May 23 03:01:00 CST 2017, time=2017-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642594, encodeId=4dee1642594df, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Aug 10 15:01:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183609, encodeId=6bac18360942, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Wed Mar 29 23:39:56 CST 2017, time=2017-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342377, encodeId=d42613423e7ea, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Mar 21 03:01:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181134, encodeId=09d118113438, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Mar 19 12:51:54 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181127, encodeId=be8618112e05, content=涨知识了,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 19 12:45:28 CST 2017, time=2017-03-19, status=1, ipAttribution=)]
    2017-03-19 Chongyang Zhang

    签到学习了很多

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2029292, encodeId=a88e202929292, content=<a href='/topic/show?id=9c52e253016' target=_blank style='color:#2F92EE;'>#相关基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72530, encryptionId=9c52e253016, topicName=相关基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Tue May 23 03:01:00 CST 2017, time=2017-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642594, encodeId=4dee1642594df, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Aug 10 15:01:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183609, encodeId=6bac18360942, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Wed Mar 29 23:39:56 CST 2017, time=2017-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342377, encodeId=d42613423e7ea, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Tue Mar 21 03:01:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181134, encodeId=09d118113438, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Mar 19 12:51:54 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181127, encodeId=be8618112e05, content=涨知识了,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 19 12:45:28 CST 2017, time=2017-03-19, status=1, ipAttribution=)]
    2017-03-19 1ddf0692m34(暂无匿称)

    涨知识了,值得学习

    0

相关资讯

免疫治疗、基因治疗和疫苗,mRNA都要插一脚了!

自上个世纪八九十年代以来,mRNA药物的研发已经走过了近30年的历程。这个过程如此艰辛而漫长,很多在几年前就从事mRNA药物研发的人,在心里已经默默地放弃它了。因为在这不长不短的几十年间,研究来研究去,需要解决的还是那几个老问题,即:如何让它安全地进去,进入之后如何保证它安全、稳定、有效地工作,这些都是瓶颈问题。 去年以来,和mRNA药物研发相关的CureVac、Arcturus、BioNT

PNAS:U2AF的不同构象在mRNA前体剪接中起着关键性作用

在基因的RNA转录本能够表达蛋白之前,它们的非编码区被一种称作剪接体的复合体移除。在一项新的研究中,德国科学家们报道这种分子复合体的一种成员的不同构象在这种移除过程中发挥着至关重要的作用。 RNA充当着将储存在DNA中的遗传信息有序地转化为合成特异性蛋白的蓝本的中间产物。在细胞核中,DNA的特定片段首先转录为mRNA前体(pre-mRNA)。在很多情形下,这些主要的RNA转录本含有打断实际的蛋白

清华学者在《自然》发文揭示新的non-stop mRNA翻译终止机制

2016年12月1日,清华大学生命科学学院、结构生物学高精尖创新中心高宁课题组和合作者在《Nature》在线发表题为Mechanistic insights into the alternative translation termination by ArfA and RF2的研究论文。该论文报道了大肠杆菌中non-stop mRNA在核糖体上的翻译终止状态复合物的高分辨冷冻电镜结构,并揭示了A

Nature:史上详细转录因子TFIID三维结构出炉,力助揭示人类基因表达秘密

你的DNA不只是控制你眼睛的颜色和你是否卷舌。你的基因含有制造你身体所有蛋白的指令,而这些指令是你的细胞让你存活所持续需要的。但是在此之前,基因表达在分子水平上如何运行的一些关键细节一直有点神秘。在一项新的研究中,来自美国加州大学伯克利分校、劳伦斯伯克利国家实验室和西班牙国家研究委员会(CSIC)罗卡索拉诺物理化学研究所的研究人员

PNAS:mRNA诊断早期卵巢癌成为可能

科学家发现卵巢癌特异性mRNA亚基,使早期诊断成为可能卵巢癌是一种致命的疾病,是出了名的难诊断治疗的癌症。加州大学圣地亚哥医学院以及Moores癌症中心科学家鉴定出了卵巢癌细胞的6个mRNA亚基(信使RNA),使早期卵巢癌的诊断成为可能。更重要的是,在这些mRNA亚基中,有些能编码针对新疗法的特殊蛋白质。这项研究成果5月25日发表在Proceedings of the National A

Nature Review:抗癌药物新靶标——mRNA

当今大多数抗癌药物作用机理是靶向肿瘤细胞的DNA或蛋白质,而加州大学伯克利分校的科学家们最近推出了一整套新的潜在目标:DNA和蛋白质之间的中介物质-mRNA。 mRNA在细胞核中转录形成,而后被编辑、穿梭到细胞质中蛋白质制造工厂——核糖体。大多数科学家认为这些分子除了有其独特的序列外,并没有作为药物针对目标的显著特点。但是,加州大学伯克利分校研究人员发现,mRNA中有一小部分编码一些与癌症有

Baidu
map
Baidu
map
Baidu
map